| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 178.948 | 202.044 | 213.205 | 220.622 | 205.480 | 183.539 | 193.199 | 212.146 | 229.613 | 259.366 |
| Total Income - EUR | 181.925 | 202.265 | 213.217 | 222.290 | 214.108 | 191.107 | 193.249 | 212.403 | 229.826 | 259.903 |
| Total Expenses - EUR | 186.091 | 204.119 | 207.967 | 214.973 | 201.672 | 181.925 | 194.078 | 204.848 | 226.804 | 252.660 |
| Gross Profit/Loss - EUR | -4.167 | -1.855 | 5.250 | 7.317 | 12.436 | 9.182 | -829 | 7.556 | 3.022 | 7.243 |
| Net Profit/Loss - EUR | -4.167 | -1.855 | 3.239 | 5.069 | 10.256 | 7.333 | -2.790 | 5.431 | 1.075 | 6.023 |
| Employees | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 4 | 3 |
Check the financial reports for the company - Farmacia Rares S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 41.960 | 39.341 | 36.904 | 35.862 | 34.408 | 32.176 | 28.959 | 63.159 | 57.204 | 51.308 |
| Current Assets | 56.536 | 46.996 | 66.070 | 59.099 | 59.564 | 62.169 | 65.238 | 64.679 | 53.848 | 58.557 |
| Inventories | 27.207 | 31.436 | 29.568 | 18.436 | 24.743 | 30.005 | 27.356 | 27.380 | 27.061 | 36.514 |
| Receivables | 26.991 | 12.448 | 29.631 | 33.110 | 24.134 | 24.798 | 24.295 | 33.656 | 23.941 | 18.928 |
| Cash | 2.337 | 3.112 | 6.871 | 7.553 | 10.687 | 7.366 | 13.586 | 3.643 | 2.846 | 3.114 |
| Shareholders Funds | 21.736 | 19.660 | 22.565 | 27.220 | 34.519 | 31.136 | 20.485 | 25.979 | 24.351 | 30.238 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 76.760 | 66.678 | 80.408 | 67.741 | 59.453 | 63.209 | 73.711 | 101.859 | 86.701 | 79.627 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Rares S.r.l.